Although only one drug in the sulfonylurea class (tolbutamide) was included in this study, it is prudent from a safety standpoint to consider that this warning may also apply to other oral hypoglycemic drugs in this class, in view of their close similarities in mode of action and chemical structure
Conclusion Exploring the link between GLP-1 medications and mental health shows we need more research
Future research and clinical trials will play a crucial role in optimizing the use of HDACi, elucidating resistance mechanisms, and identifying the most effective combinations to maximize patient benefit
That disconnect is what led us to create the Price & Trust Transparency Score, a way to cut through surface-level promises and evaluate clinics on what actually matters
10.1016/s2213-8587(17)30013-x [DOI] [PubMed] [Google Scholar] Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B